johnsondiversey (east africa) - Gale

00081 JOHNSONDIVERSEY (EAST AFRICA) . . . KENYA 

PRINCIPAL ACTIVITIES: Manufacture of household products 

including detergents, bleaches, disinfectants, shampoos 

and gels 

Status: Private Company 

00081 

JOHNSONDIVERSEY (EAST AFRICA) LTD 

Address: PO Box 41939, Kaptagat Road, 00100 Nairobi 

International tel: +254 (20) 422 4000 

International fax: +254 (20) 422 4888 

Website: www.johnsondiversey.com 

PRINCIPAL ACTIVITIES: Manufacture of household cleaning 

products 

Company History: May 2002: The company acquired DiverseyLever 

to become JohnsonDiversey 

Parent Company: JohnsonDiversey, USA 


Principal Shareholders: JohnsonDiversey, USA 

00082 

KAPI LTD 

Address: PO Box 252, Nakuru 



Company email: kapiltd@africaonline.co.ke 

Website: www.kapikenya.com 

PRINCIPAL ACTIVITIES: Manufacture of Pyrethrum based 

insectides including mosquito coils and handicrafts 

Major Products: mosquito coils; joss sticks; pet shampoo; 

jigsaw puzzles; mirrors 


Date of Establishment: 1964 

00083 

KEL CHEMICALS LIMITED 

Address: PO Box 40971, ABC Place, Waiyaki Way, 00100 

Nairobi 



Company email: sales@kelchemicals.com 

Website: www.kelchemicals.com 

PRINCIPAL ACTIVITIES: Manufacture of and export trade in 

chemicals including sulphuric acid, aluminium sulphate and 

sodium sulphate 


00084 

KENYA FLUORSPAR COMPANY LIMITED 

Address: 4th Fl Ya-Ya Centre, Argwing Kodhek Avenue, 

Nairobi 



Company email: info@kenyafluorspar.co.ke 

Website: www.kenyafluorspar.com 

Board of Directors: Charles Field-Marsham (Chairman), 

Nicholas Davidoff (Director), Andre De Simone (Non- 

Executive Director), Chris D Groom (Non-Executive Director), 

Raphael M Thyaka (Non-Executive Director) 

Management: Subrata Chakraborty (Plant Process Manager), 

Doon de Bruyn (Maintenance Manager), Pablo Dyre (Head 

of Sales and Marketing), Johan Ferreira (Chief Financial 

Officer), Charles K Korir (Human Resources Manager), 

Thangaveu Kumar (Plant Maintenance Manager), K S 

Samoei (Laboratory Manager), Nico Spangenberg (Managing 

Director) 

PRINCIPAL ACTIVITIES: Exploratory drilling and the operation 

of mines and fluorspar concentrator 


Principal Shareholders: Firebird Management LLC 


00085 

KENYA PETROLEUM REFINERIES LTD 

Address: PO Box 90401, Refinery Road, Changamwe, 

80100 Mombasa 



Company email: refinery@kprl.co.ke 

Website: www.kprl.co.ke 

Board of Directors: Suleiman R Shakombo (Chairman), 

Lawrence T Gatama (Alternate Director), Hesbon Gondi 

(Director), Festus W King’ori (Alternate Director), Joseph 

Kinyua (Director), Naresh Nayyar (Director), Patrick Nyoike 

8 

(Director), Prashant Ruia (Director), Narendra Vachharajani 

(Director), Raj K Varma (Director) 

Management: Andrew Harvey (Manufacturing Manager), 

John Mruttu (General Manager), Reuben Ndinya (Finance 

Manager), Charles Nguyai (Engineering Manager), Martin 

Wahome (Human Resources Manager) 

PRINCIPAL ACTIVITIES: Refinery and distribution of petroleum 

Company History: The Kenya Petroleum Refineries Limited 

was originally set up by Shell and the British Petroleum 

Company (BP) to serve the East African region in the supply 

of a wide variety of oil products. The Company was incorporated 

in 1960, under the name East African Oil Refineries 

Limited. On 31st July 2009 ESSAR Energy of India acquired 

a 50% stake of KPRL 


Principal Shareholders: Government of Kenya (50%); Essar 

Energy Overseas Ltd (50%) 


00086 

MAGADI SODA COMPANY LTD 

Address: PO Box 1, 00205 Magadi 



Company email: info@magadisoda.co.ke 

Website: www.magadisoda.co.ke 

Management: Satyajit Ghoshal (Finance Director), Eliud 

Kayongo (Director of Manufacturing), James Mathenge 

(Managing Director), Mike Odera (Sales and Marketing Director), 

Dominic Ooko (Human Resources Director), Dr Sam 

Wendo (Senior Medical Officer) 

PRINCIPAL ACTIVITIES: Production of and export trade in 

soda ash 

Parent Company: Brunner Mond Group Ltd (06742) 


Principal Shareholders: Brunner Mond Group (100%) 


No of Employees: 450 

00087 

MOMBASA SALT WORKS LTD 

Address: PO Box 84411, 80100 Mombasa 



PRINCIPAL ACTIVITIES: Manufacture of salt products 

Major Products: Table Salt; Bakery Salt; Cattle Salt 


00088 

NAIROBI PLASTICS LTD 

Address: PO Box 49086, Rangwe Road, off Lunga Lunga 

Road, Industrial Area, 00100 Nairobi 

International tel: +254 (20) 550961 

International fax: +254 (20) 650161 

PRINCIPAL ACTIVITIES: Manufacture of household plastics, 

sheeting and bags 



00089 

OLYMPIA CAPITAL HOLDINGS LIMITED 

Address: PO Box 30102, Off Nanyunki Road, Industrial Area, 

00100 Nairobi 


International fax: +254 (20) 650048 

Company email: info@dunvon.com 

Board of Directors: Chris W Obura (Chairman), Michael Matu 

(Chief Executive Officer), Mwangi Wamae (Chief Operations 

Officer) 

PRINCIPAL ACTIVITIES: Manufacture of adhesives and 

sealants 

Subsidiary Companies: (100% owned unless stated): Dunlop 

Industries Limited 

Associated Companies: Olympia Capital Corporation 

(Botswana) 

Auditors: Grant Thornton 

Ticker Symbol: OLYM 

Stock Exchange: Nairobi 

ISIN: KE0000000166 

Status: Public Company 


Financial Information: 

28.2.08 28.2.09 

KShs’000 KShs’000 

Sales turnover 1,372,346 517,357 

Profit before tax 37,816 66,387 

Profit (loss) after tax 16,143 (56,919) 

Dividend 8,000 8,000 

Dividend per share KShs0.20 KShs0.10 

Earnings (loss) per share KShs0.40 (KShs1.42) 

Share capital 50,000 – 

Shareholders’ equity 571,731 463,092 

00090 

ORBIT CHEMICAL INDUSTRIES LTD 

OCIL 

Address: PO Box 48870, 00100 Nairobi 



Company email: orbit@orbitchem.com 

Website: www.orbitchem.com 

PRINCIPAL ACTIVITIES: Manufacture of soaps and detergents 

and agrochemicals; trade in industrial chemicals and 

fertilizers 




00091 

PWANI OIL PRODUCTS LIMITED 

Address: PO Box 81327, Wahunzi St, Mombasa 



Company email: info@pwanioilproducts.com 

Website: www.pwanioilproducts.com 

Board of Directors: Ramesh K Malde (Chairman and Chief 

Executive Officer), Anil K Malde (Managing Director) 

Management: Rajul Malde (Sales Director), Naresh Malde 

(Operations Director), Rajan Malde (Finance, IT and Admin 

Director), Mrs Aarti Malde (Export Manager), Raphael 

Marende (Factory Manager), John Nyambok (Chief Operations 

Officer), Mrs Stella Wandario (Chief Marketing Officer) 

PRINCIPAL ACTIVITIES: Manufacture of edible oils, fat and 

laundry bar soap 

Trade Names: Bakemate, Fryking, Fresh Fri, Fry mate Diria, 

Popco Koboko, Mpishi poa, Diria, Pwani SBF, Salit, White 

wash Ndume, Mzuri 



00092 

PZ CUSSONS EAST AFRICA LTD 

Former name: Cussons & Company Ltd 

Address: PO Box 48597, Baba Dogo Road, Ruarka, 00100 

Nairobi 

International tel: +254 286 0711 

Website: www.pzcussons.com 

Management: George Sotiropoulos (Managing Director) 

PRINCIPAL ACTIVITIES: Manufacture of toiletries, soaps and 

medicines 

Trade Names: Imperial Leather, Venus, Robb, Ushindi Laundry 

soap 

Parent Company: PZ Cussons Plc (06918) 


Principal Shareholders: PZ Cussons Plc (100%) 


00093 

SANOFI-AVENTIS (K) LTD 

Address: PO Box 20337, Roshanmaer Place 2nd Fl, Lenana 

Road, Milimani, 00200 Nairobi 



Website: www.sanofi-aventis.com 

PRINCIPAL ACTIVITIES: Manufacture and distribution of 

vaccines 

Parent Company: sanofi-aventis SA (04671) 


Principal Shareholders: sanofi-aventis SA

PRINCIPAL ACTIVITIES: Manufacture and sale of solvents and 

flat glass 

Trade Names: Triangle Solvents 

Branch Offices: Bloemfontein; Cape Town; Durban; East 

London; George; Johannesburg; Nelspruit; Port Elizabeth 




00280 

NIMUE SKIN TECHNOLOGY SA (PTY) LTD 

Address: PO Box 4383, Rivonia 2128 



Company email: nimue@nimueskin.com 

Website: www.nimueskin.com 

PRINCIPAL ACTIVITIES: Development of skin rejuvenation 

treatment products 




00281 

NORGINE (PTY) LTD 

Address: PO Box 781247, Sandton 2146 



Company email: norgine.south.africa@norgine.com 

Website: www.norgine.com 

PRINCIPAL ACTIVITIES: Development, manufacture and 

marketing of pharmaceuticals 

Parent Company: Norgine International Ltd, UK 


Principal Shareholders: Norgine International Ltd 

00282 

AJ NORTH (PTY) LTD 

Address: PO Box 716, 8 Thor Circle, Viking Business Park, 

Thornton, Cape Town 8000 



Company email: ajn@ajnorth.co.za 

Website: www.ajnorth.co.za;www.happyevent.co.za 

Management: Chris J Watkins-Baker (Finance Director) 

PRINCIPAL ACTIVITIES: Manufacture of toiletries and toothbrushes 

Trade Names: Glyco Lemon, Happy Event, Hygiene & Magnum 

Branch Offices: Cape Town; Durban; East London; Johannesburg 

Parent Company: RCL Investments (Pty) Ltd 

Principal Banks: Standard Bank of South Africa Ltd 

Auditors: Campbell & Co 

Principal Law Firm: Fairbridge Arderne & Lawton 


Principal Shareholders: RCL Investments (Pty) Ltd 




30.6.07 30.6.08 

Rand’000 Rand’000 

Sales turnover 38,000 40,000 

00283 

NOVARTIS SOUTH AFRICA (PTY) LTD 

Address: PO Box 92, Isando 1600 



Website: www.novartis.co.za 

Company Registration Number: 1946/020671/07 

Board of Directors: H-J Beger (Chairperson) 

Management: M N Guliwe (Country Head), Y-E J Sautter 

(Company Secretary), A van der Merwe (Managing Director) 

PRINCIPAL ACTIVITIES: Manufacture and marketing of healthcare 

and agribusiness products 

Parent Company: Novartis International AG (06600) 

Subsidiary Companies: (100% owned unless stated): Sandoz 

South Africa (Pty) Ltd 


Principal Shareholders: Novartis International AG, Switzerland 

(100%) 



SOUTH AFRICA PLAASKEM (PTY) LTD 00289 

00284 

NOVO NORDISK PTY LTD 

Address: PO Box 783155, Sandton 2146 



Website: www.novonordisk.com;www.novonordisk.co.za 

Management: Jenny Wallis (Head of Office) 

PRINCIPAL ACTIVITIES: Research, production and marketing 

of pharmaceuticals 

Parent Company: Novo Nordisk A/S (04148) 


Principal Shareholders: Novo Nordisk A/S, Denmark (100%) 

00285 

NTP RADIOISOTOPES (PTY) LTD 

Address: PO Box 582, Pretoria 0001 



Company email: marketing@ntp.co.za 

Website: www.radioisotopes.co.za 

Management: Dr Rob Adam (Chief Executive Officer) 

PRINCIPAL ACTIVITIES: Provision of nuclear technology products 

for the diagnosis and treatment of illnesses 

Parent Company: South African Nuclear Energy Corporation 

Limited (00278) 


Principal Shareholders: South African Nuclear Energy Corporation 

Limited (100%) 

00286 

OMNIA HOLDINGS LIMITED 

Address: PO Box 69888, Bryanston 2021 



Company email: group@omnia.co.za 

Website: www.omnia.co.za 

Company Registration Number: 1967/003680/06 

Board of Directors: Neville J Crosse (Chairman), Frank D 

Butler (Non-Executive Director), Delwin L Eggers (Group 

Finance Director), Noel K H Fitz-Gibbon (Commercial Director), 

Ralph Havenstein (Non-Executive Director), Hester 

Hickey (Non-Executive Director), Rod B Humphris (Group 

Managing Director), Prof Stephanus S Loubser (Non- 

Executive Director), Dr Willie T Marais (Non-Executive 

Director), Raisaka Masebelanga (Executive Director Legal 

and Business Development), Johan G Pretorius (Non- 

Executive Director), Diane Radley (Non-Executive Director), 

Rod Scott (Non-Executive Director) 

Management: Celeste Appollis (Company Secretary), Gavin 

Brimacombe (Joint Managing Director Protea Chemicals), 

Edu Cloete (Joint Managing Director Protea Chemicals), 

Trevor Grant (Managing Director Omnia Fertilizer), Francois 

Hay (Managing Director BME), Johan Möller (Human 

Resources Director) 

PRINCIPAL ACTIVITIES: Specialist chemical services company 

providing customised chemical solutions in the chemical, 

mining and agriculture markets. Its subsidiaries are 

involved in the manufacture, distribution and trade of fertilizers, 

speciality fertilizers, mining explosives and industrial 

chemicals 

Joint Ventures: NWK/Omnia Kunsmis Agency Agreement 

(50%); Acol Chemicals (Private) Ltd (50%) 

Subsidiary Companies: (100% owned unless stated): Banket 

Blender (Pvt) Ltd (Zimbabwe); Bulk Mining Explosives 

Botswana Ltd (Botswana); Bulk Mining Explosives Mali Sarl 

(Mali); Bulk Mining Explosives Mauritania Sarl (Mauritania); 

Bulk Mining Explosives Namibia (Pty) Ltd (Namibia); Bulk 

Mining Explosives (Pty) Ltd; Bulk Mining Explosives Senegal 

Sarl (Senegal); Bulk Mining Explosives Tanzania (Pty) Ltd 

(Tanzania); Bulk Mining Explosives Zambia Ltd (Zambia); 

Chemical Holdings Ltd (Bermuda); Delta Caps Initiators SAS 

(France); EcoGypsum (Pty) Lted; Imphort (Pvt) Ltd (Zimbabwe); 

Intaba Hydrates (Pty) Ltd; Nitrochem (Pty) Lted; 

Omnia Crop Science (Pty) Ltd (Australia); Omnia do Brasil 

Representações Comerciais Limitada (Brazil); Omnia Fertilizer 

Kenya Ltd (Kenya); Omnia Fertilizer Ltd; Omnia Fertilizer 

Ltd (Malawi); Omnia Fertilizer Zambia Ltd (Zambia); Omnia 

Fertilizer Zimbabwe (Pvt) Ltd (Zimbabwe); Omnia Group 

International Limited (Mauritius); Omnia Group Investments 

Limited; Omnia Group (Pty) Ltd; Omnia International (Australia) 

Pty Ltd (Australia); Omnia Primaxa Ltd (75%) (New 

Zealand); Omnia Small Scale Ltd (Zambia); Omnia Specialities 

(Australia) Pty Ltd (Australia); Omnia Specialities NZ Ltd 

(New Zealand); Omnia Specialities (Pty) Ltd; Omnia Swaziland 

Ltd (Swaziland); Protea Chemicals (Pty) Ltd; Zetachem 

(Pty) Ltd 

Auditors: PricewaterhouseCoopers Inc 

Ticker Symbol: OMN 

Stock Exchange: Johannesburg 

ISIN: ZAE000005153 


Principal Shareholders: Oasis Crescent Management 

(14.9%); Dr W T Marais and related Trusts (13.2%); Regarding 

Capital Management (11.2%); Old Mutual Investment 

Corporation (11%); Coronation Fund Managers 

(6.8%); Investec Asset Management (5%) 


No of Employees: 2,498 (Group) 


31.3.08 31.3.09 

Rand’000 Rand’000 

Sales turnover 7,340,000 11,111,000 


Profit after tax 313,000 491,000 

Dividend per share 200.0c 250.0c 

Earnings per share 687.9c 1,067.2c 

Share capital 188,000 188,000 

Shareholders’ equity 1,581,000 2,137,000 

00287 

ORCHEM (PTY) LTD 

Address: PO Box 581, Bruma 2026 



Website: www.latex-sa.co.za 

Board of Directors: Dr A J Brink (Chief Executive Officer), D T 

Blackburn (Director), P J Steenkamp (Director) 


quality industrial chemicals to the rubber industry 

Parent Company: Karbochem (Pty) Ltd (00266) 


Principal Shareholders: Karbochem (Pty) Ltd (100%) 

00288 

PHARMA DYNAMICS 

Address: PO Box 30958, Tokai 7966 



Company email: info@pharmadynamics.co.za 

Website: www.pharmadynamics.co.za 

Management: Priscilla Adams (Purchasing & Logistics Coordinator), 

Paul Anley (Managing Director), Fanie Delport 

(Regulatory & Technical Services Manager), Dianne Haantjes 

(PA & Operations Manager), Brent Kleve (National Sales 

Executive), Bettina Meyer (Finance Manager), Roger Moult 

(Group Product Manager), Cheree Muller (Regulatory Affairs 

Manager), Aadila Patel (Regulatory Affairs Manager), 

Tommy Scott (Business Development Director) 

PRINCIPAL ACTIVITIES: Manufacture of pharmaceutical products 


00289 

PLAASKEM (PTY) LTD 

Address: PO Box 14418, Witfield 1467 



Company email: info@plaaskem.co.za 

Website: www.plaaskem.co.za;www.chemserve.co.za 

Management: Jurgens Bornman (Manager for Mpumalanga 

and N Province), Quintin Cross (Business Development 

Director), Eugene de Wet (Manager for Africa), Butch 

Horstman (Operations Manager), Salim Khan (Financial 

Manager), Vanessa Kirkby (Procurement Officer), Koos Kriel 

(Manager Retail), Hugo Minaar (Managing Director), Pieter 

Potgieter (Manager Bulk Nutrition), Karin Stoll (Manager 

Wholesale), Rudi Viljoen (Manager for WOFS, N West and 

N Cape), Alwyn Vorster (Area Manager for Gauteng, Highveld 

and EOFS), Dene Zondagh (Technical and Commercial 

Manager) 

PRINCIPAL ACTIVITIES: Manufacture of specialised chemical 

products for the Agricultural, Water Treatment, Veterinary 

and the Casting Solutions markets 

Parent Company: Chemical Services Ltd (00224) 

Subsidiary Companies: (100% owned unless stated): UAP 

Crop Care (Pty) Ltd 


27

01056 PHARMAXIS LTD AUSTRALIA 


No of Employees: 1,150 


30.11.07 30.11.08 

A$’000 A$’000 


01056 

PHARMAXIS LTD 

Address: Unit 2, 10 Rodborough Road, Frenchs Forest, NSW 

2086 

International tel: +61 (2) 9454-7200 

International fax: +61 (2) 9451-3622 

Company email: info@pharmaxis.com.au 

Website: www.pharmaxis.com.au 

Board of Directors: Denis Hanley (Chairman), Dr Alan D 

Robertson (Chief Executive Officer), William Delaat (Non- 

Executive Director), Peter Farrell (Non-Executive Director), 

Malcolm McComas (Non-Executive Director), David Mc- 

Garvey (Chief Financial Officer and Company Secretary), 

Richard van den Broek (Non-Executive Director), John W 

Villiger (Non-Executive Director) 

Management: Brett Charlton (Medical Director), John F Crapper 

(Chief Operations Officer), Howard G Fox (Chief Medical 

Officer), Ian A McDonald (Chief Scientific Officer), Gary J 

Phillips (Commercial Director) 

PRINCIPAL ACTIVITIES: Research, development and marketing 

of pharmaceuticals for the treatment of respiratory and 

autoimmune diseases 

Subsidiary Companies: (100% owned unless stated): Pharmaxis 

Inc (USA); Pharmaxis Pharmaceuticals Limited (UK) 

Principal Banks: Westpac Banking Corporation; HSBC Bank 

Australia Ltd 

Auditors: PricewaterhouseCoopers 

Principal Law Firm: PFM Legal Pty Ltd; Venable LLP 

Ticker Symbol: PXS 

Stock Exchange: Australia 

ISIN: AU000000PXS5 


Principal Shareholders: National Nominees Ltd (21.1%); 

Citicorp Nominees Pty Ltd (13.8%); HSBC Custody Nominees 

(Australia) Ltd (8.9%); JP Morgan Nominees Australia 

Limited (8.4%) 



30.6.08 30.6.09 

A$’000 A$’000 

Revenue 7,402* 5,347* 

(Loss) before tax (20,408) (35,120) 

(Loss) after tax (20,440) (35,171) 

(Loss) per share (10.8c) (18.0c) 



*Total revenue 

01057 

PPG INDUSTRIES AUSTRALIA PTY LTD 

Address: 14 McNaughton Road, Clayton, VIC 3168 



Website: corporateportal.ppg.com/ppg/ 

Company Registration Number: ACN 055 500 939 

Management: Greg Decamp (Managing Director) 

PRINCIPAL ACTIVITIES: Manufacture of paints for industrial, 

marine, offshore, building and construction purposes 

Parent Company: PPG BV (05816) 


Principal Shareholders: PPG BV, Netherlands 



31.12.07 31.12.08 

A$’000 A$’000 

Revenue 368,435 476,060 

01058 

PZ CUSSONS AUSTRALIA PTY LTD 

Address: 282-300 Hammond Road, Dandenong, VIC 3175 


Website: www.pzcussons.com 


Management: George Fatouros (Managing Director) 

116 

PRINCIPAL ACTIVITIES: Manufacture and marketing of household 

detergents, bar soaps, men’s toiletries and dishwashing 

liquids 

Trade Names: Radiant; Duo; Reflect; Morning Fresh; Imperial 

Leather; Pure; Pearl; Preservene and Graphite 

Parent Company: PZ Cussons Plc (06918) 


Principal Shareholders: PZ Cussons Plc, UK (100%) 



31.5.07 31.5.08 

A$’000 A$’000 


01059 

QENOS HOLDINGS PTY LTD 

Address: 417 Kororoit Creek Road, Altona, VIC 3018 



Company email: enquiry@qenos.com 

Website: www.qenos.com 


Management: Jonathan Clancy (Chief Executive Officer) 

PRINCIPAL ACTIVITIES: Manufacture and sale of petrochemicals 

and polyethylene resin 

Major Products: Ethylene; polyethylene 

Trade Names: Qenos 

Parent Company: China National Chemical Corporation 

(02477) 

Subsidiary Companies: (100% owned unless stated): Olefins 

Pty Ltd; Qenos Elastomers Pty Ltd; Qenos Olefins Pty Ltd; 

Qenos Plastics Pty Ltd; Qenos Pty Ltd; Qenos Resins Pty Ltd 


Principal Shareholders: China National BlueStar (Group) 

Corporation, People’s Republic of China 

Date of Establishment: 1 July 1999 



31.12.07 31.12.08 

A$’000 A$’000 

Revenue 903,790 857,945 

01060 

QUEENSLAND ALUMINA LIMITED 

QAL 

Address: Parson’s Point, Gladstone, QLD 4680 



Company email: media@qal.com.au 

Website: www.qal.com.au 


Board of Directors: S Wensley (Chairman), P Cambell 

(Managing Director), C Salisbury (Executive Director), A 

Shmalenko (Executive Director) 

PRINCIPAL ACTIVITIES: Operation of a refinery to process 

bauxite into alumina 

Status: Non Quoted Public Company 



01061 

RECKITT BENCKISER (AUSTRALIA) PTY 

LTD 

Address: 44 Wharf Road, West Ryde, NSW 2114 



Company email: Consumer_Inquiry@reckittbenckiser.com 

Website: www.reckittbenckiser.com 


Management: Lindsay Forrest (Regional Director Australasia 

and New Zealand) 

PRINCIPAL ACTIVITIES: Production of household and personal 

care products 

Parent Company: Reckitt Benckiser plc (06921) 


Principal Shareholders: Reckitt Benckiser plc, UK (100%) 



31.12.07 31.12.08 

A$’000 A$’000 


01062 

RIDLEY CORPORATION LTD 

Address: Level 4, 565 Bourke Street, Sydney, NSW 2000 



Company email: secretary@ridley.com.au 

Website: www.ridley.com.au 


Board of Directors: John S Keniry (Chairman), Richard J Lee 

(Deputy Chairman), Patria M Mann (Non-Executive Director), 

John Murray (Managing Director and Chief Executive Officer), 

John M Spark (Non-Executive Director), Prof Andrew 

Vizard (Non-Executive Director) 

Management: Alan Boyd (Chief Financial Officer and Company 

Secretary), W H Fell (General Manager Sales and 

Marketing Ridley AgriProducts), C Klem (Strategy and 

Corporate Development Manager), R N Lyons (General 

Manager Corporate Development Ridley AgriProducts), A M 

Mooney (General Manager Commercial Ridley Corporation), 

A L Speed (General Manager Cheetham Salt), G P Watts 

(General Manager Finance), P J Weaver (Chief Operating 

Officer Ridley AgriProducts) 

PRINCIPAL ACTIVITIES: Stockfeed milling and marketing; 

production of crude salt, salt refining and marketing; swine 

genetics and production; provision of rural products and 

services 

Divestments: 2009: sale of Ridley Inc 

Joint Ventures: Champion Liquid Feeds (50%); Ridley TSS 

(50%) 

Subsidiary Companies: (100% owned unless stated): Barastock 

Stockfeeds Pty Ltd (New Zealand); Barastock Stockfeeds 

Pty Ltd; Cheetham Salt Ltd; Diamond Salt Pty Ltd; 

RCL Investments Pty Ltd; RCL Nominees Ltd; RCL Retirement 

Pty Ltd; Ridley Agriproducts Pty Ltd; Ridley M I Pty 

Ltd; Ridley Research & Development Corporation Pty Ltd 

Auditors: PricewaterhouseCoopers 

Ticker Symbol: RIC 

Stock Exchange: Australia 

ISIN: AU000000RIC6 


Principal Shareholders: National Nominees Ltd (18.56%); 

RBC Dexia Investor Services Aust Nominees (BKCUST A/C) 

(12.11%); HSBC Custody Nominees (Aust) Ltd (8.78%); 

J P Morgan Nominees Australia Ltd (7.24%); RBC Dexia 

Investor Services Australia Nominees (6.04%) 


No of Employees: 638 (Group) 


30.6.08 30.6.09 

A$’000 A$’000 

Revenue 837,608 819,437 



Dividend 20,586 21,075 

Dividend per share 7.0c 7.0c 

Earnings per share 3.6c 4.3c 



01063 

ROCHE PRODUCTS PTY LIMITED 

Address: 4-10 Inman Road, Dee Why, NSW 2099 



Website: www.roche-australia.com 


Management: F A Nadjarian (Managing Director) 


pharmaceuticals and chemical products 

Parent Company: Roche Holding AG (06611) 

Subsidiary Companies: (100% owned unless stated): 

Colburn-Dawes Australia Pty Ltd; Syntex Australia Ltd 


Principal Shareholders: Roche Holding AG, Switzerland 

(100%) 




31.12.07 31.12.08 

A$’000 A$’000 

Sales turnover 571,230 531,840

01842 ASAHI ORGANIC CHEMICALS . . . JAPAN 

Hangzhou Asahikasei Spandex Co Ltd (People’s Republic of 

China); Hangzhou Asahikasei Textiles Co Ltd (82.5%) (People’s 

Republic of China); Japan Elastomer Co Ltd (75%); 

Kyokuyo Sangyo Co Ltd; Sanyo Petrochemical Co Ltd; Sun 

Plastech Inc (USA); Sun Trading Co Ltd; Thai Asahi Kasei 

Spandex Co Ltd (60%) (Taiwan); Tongsuh Petrochemical 

Corporation Ltd (South Korea) 

Auditors: PricewaterhouseCoopers Aarata 

Ticker Symbol: 3407 

Stock Exchange: Tokyo 


Principal Shareholders: Master Trust Bank of Japan (6.18%); 

Japan Trustee Services Bank (trust account 4G) (6.03%); 

Japan Trustee Services Bank (trust account) (5.75%); Nippon 

Life Insurance Co (5.22%) 

Date of Establishment: 21 May 1931 

No of Employees: 24,244 (group) 


31.3.08 31.3.09 

¥’000 ¥’000 

Sales turnover 1,696,789,000 1,553,108,000 

Profit before tax 105,599,000 19,031,000 

Profit after tax 69,945,000 4,745,000 

Dividend per share 13.00¥ 10.00¥ 

Earnings per share 50.01¥ 3.39¥ 

Share capital 103,389,000 103,389,000 


01842 

ASAHI ORGANIC CHEMICALS INDUSTRY CO 

LTD 

Address: 2-5955 Nakanose-machi, Nobeoka 882-8688, 

Miyazaki Pref 


Website: www.asahi-yukizai.co.jp 

Board of Directors: Yoichi Saji (President) 

PRINCIPAL ACTIVITIES: Manufacture of plastic valves and 

synthetic resin products 

Branch Offices: Tokyo 




Principal Shareholders: Asahi Kasei (29.4%) 

Date of Establishment: March 1945 



31.3.08 31.3.09 

¥’000 ¥’000 


Profit (loss) after tax 1,370,000 (2,915,000) 


Earnings (loss) per share 14.00¥ (29.80¥) 

Share capital 5,000,000 5,000,000 


01843 

ASAHI RUBBER INC 

Address: 2-7-2 Dote-machi, Omiya-ku, Saitama, Saitama 

330-0801 


Website: www.asahi-rubber.co.jp 

Board of Directors: Shigeyoshi Yokoyama (President) 

PRINCIPAL ACTIVITIES: Manufacture of silicone rubber 

Subsidiary Companies: (100% owned unless stated): Ari 

International Corporation (USA); Fine Rubber Laboratories 

Co Ltd 


Stock Exchange: Jasdaq 


Principal Shareholders: Iwao Ito (22.8%) 

Date of Establishment: June 1976 



31.3.08 31.3.09 

¥’000 ¥’000 


Profit (loss) after tax 210,000 (80,000) 


Earnings (loss) per share 46.4¥ (17.6¥) 



224 

01844 

ASAHIPEN CORPORATION 

Address: 4-1-12 Tsurumi, Tsurumi-ku, Osaka 538-8666 



Website: www.asahipen.jp 

Board of Directors: Takeshi Tanaka (President) 

PRINCIPAL ACTIVITIES: Manufacture of paints for home 

decorating, wallpapers and floor polish 


Stock Exchange: Osaka 


Date of Establishment: September 1947 

No of Employees: 305 (group) 


31.3.08 31.3.09 

¥’000 ¥’000 





Share capital 5,870,000 5,870,000 


01845 

ASKA PHARMACEUTICAL CO LTD 

Former name: Teikoku Hormone Mfg Co Ltd 

Address: 2-5-1 Shibaura, Minato-ku, Tokyo 108-8532 



Website: www.aska-pharma.co.jp 

Board of Directors: Takashi Yamaguchi (President) 

PRINCIPAL ACTIVITIES: Manufacture of pharmaceuticals, 

especially medicines for the digestive system and hormonal 

drugs 




Principal Shareholders: Takeda Pharmaceutical (7.2%); 

Company’s Trust Stock (6.8%) 

Date of Establishment: June 1929 



31.3.08 31.3.09 

¥’000 ¥’000 


Profit after tax 3,515,000 600,000 



Share capital 1,195,000 1,195,000 


01846 

ASTELLAS PHARMA INC 

Former name: Yamanouchi Pharmaceutical Co Ltd 

Address: 2-3-11 Nihonbashi-Honcho, Chuo-ku, Tokyo 103- 

8411 



Website: www.astellas.com 

Board of Directors: Toichi Takenaka (Chairman), Takako Ebata 

(Director), Yasuo Ishii (Executive Vice President, Chief Sales 

and Marketing Officer), Masafumi Nogimori (President and 

Chief Executive Officer), Takao Saruta (Director), Yasuyuki 

Takai (Director), Shiro Yasutake (Director) 

Management: Masaharu Asano (Corporate Officer), Masaki 

Doi (Corporate Officer), Yoshihiko Hatanaka (Senior Corporate 

Officer), Rinta Ibuki (Corporate Officer), Michirou 

Ikeda (Corporate Officer), Masaru Imahori (Corporate Officer), 

Seigo Kashii (Corporate Officer), Shinichiro Katayanagi 

(Corporate Officer), Fujio Kitamura (Corporate Officer), Yasumasa 

Masuda (Corporate Officer), Iwaki Miyazaki (Senior 

Corporate Officer), Yoshiro Miyokawa (Senior Corporate 

Officer), Seitaro Mutoh (Corporate Officer), Kohei Nomoto 

(Corporate Officer), Hitoshi Ohta (Senior Corporate Officer), 

Hirofumi Seki (Corporate Officer), Hidetoshi Shuto 

(Corporate Officer), Shin-ichi Tsukamoto (Senior Corporate 

Officer), Katsuro Yamada (Senior Corporate Officer), Masao 

Yoshida (Corporate Officer) 

Senior Executives: Shigeo Aoyagi (Corporate Auditor), Osamu 

Nagai (Corporate Auditor), Kiyomi Saito (Corporate Auditor), 

Hideo Yamada (Corporate Auditor) 

PRINCIPAL ACTIVITIES: Manufacture of pharmaceuticals: 

antibiotics, metabolic drugs, circulatory system agents 

Company History: April 2005: merger of Yamanouchi Pharmaceutical 

Co Ltd and Fujisawa Pharmaceutical Co Ltd 

Trade Names: Starsis, Libian, Lipitor (R), Harnal (R) 

Branch Offices: Nagoya; Osaka; Sapporo; Sendai; Takamatsu; 

Tokyo; Hiroshima; Fukuoka; Kobe; Yokohama; Kyoto; 

Seoul; Beijing; Manila; Jakarta 

Subsidiary Companies: (100% owned unless stated): Astellas 

BV (Netherlands); Astellas Farma Brasil Importação e 

Distribuição de Medicamentos Ltda (Brazil); Astellas Farma 

Ltda (Portugal); Astellas Ireland Co Ltd (Republic of Ireland); 

Astellas Pharma A/S (Denmark); Astellas Pharma AG 

(Switzerland); Astellas Pharma BV (Netherlands); Astellas 

Pharma Canada Inc (Canada); Astellas Pharma Chemicals 

Co Ltd; Astellas Pharma China Inc (People’s Republic 

of China); Astellas Pharma Co Ltd (Republic of Ireland); 

Astellas Pharma Europe BV (Netherlands); Astellas Pharma 

Europe Ltd (UK); Astellas Pharma GesmbH (Austria); Astellas 

Pharma Global Development Inc (USA); Astellas Pharma 

GmbH (Germany); Astellas Pharma Hong Kong Co Ltd (Hong 

Kong SAR); Astellas Pharma Ilaç Ticaret ve Sanayi Anonim 

Sirketi (Turkey); Astellas Pharma International BV (Netherlands); 

Astellas Pharma Kft (Hungary); Astellas Pharma 

Korea Inc (South Korea); Astellas Pharma Ltd (UK); Astellas 

Pharma Philippines Inc (Philippines); Astellas Pharma Pty 

Ltd (South Africa); Astellas Pharma SA (Spain); Astellas 

Pharma SAS (France); Astellas Pharma Sp zoo (Poland); 

Astellas Pharma SpA (Italy); Astellas Pharma sro (Czech 

Republic); Astellas Pharma Taiwan Inc (Taiwan); Astellas 

Pharma Technologies Inc (USA); Astellas Pharma (Thailand) 

Co Ltd (Thailand); Astellas Pharma US Inc (USA); Astellas 

Pharmaceuticals AEBE (Greece); Astellas Research Institute 

of America LLC (USA); Astellas Tokai Co Ltd; Astellas 

Toyama Co Ltd; Astellas US Holding Inc (USA); Astellas 

US LLC (USA); Astellas US Technologies Inc (USA); Astellas 

Venture Management LLC (USA); PT Astellas Pharma 

Indonesia (Indonesia); Urogenix Inc (USA); ZAO Astellas 

Pharma (Russia) 

Auditors: Ernst & Young ShinNihon LLC 




Principal Shareholders: Japan Trustee Services Bank (trust 

account 4G) (5.76%); Japan Trustee Services Bank (trust 

account) (5.66%); The Master Trust Bank of Japan Ltd 

(trust account) (5.12%) 

Date of Establishment: March 1939 



31.3.08 31.3.09 

¥’000 ¥’000 


Profit before tax 268,778,000 262,692,000 

Profit after tax 177,438,000 170,986,000 



Share capital 103,001,000 103,001,000 

Shareholders’ equity 1,092,906,000 1,081,874,000 

01847 

ATOMIX CO LTD 

Address: 3-9-6 Funado, Itabashi-ku, Tokyo 174-8574 


Website: www.atomix.co.jp 

Board of Directors: Kazuyuki Kobayashi (President) 

PRINCIPAL ACTIVITIES: Manufacture of road marking paint 

and other synthetic resin paints 


Stock Exchange: Jasdaq 


Principal Shareholders: Nishikawa Fudosan (33.6%); Customers’ 

Stockholding (11.7%); Company’s Trust Stock 

(10.5%); Tokyo Small Bus. Investment (7.4%) 

Date of Establishment: May 1948 



31.3.08 31.3.09 

¥’000 ¥’000 


(Loss) after tax (300,000) (129,000) 


(Loss) per share (35.2¥) (15.3¥) 

Share capital 1,040,000 1,040,000 

Shareholders’ equity 9,350,000 8,882,000

johnsondiversey (east africa) - Gale

Create successful ePaper yourself

Delete template?

Save as template?